For example, loss of function of HDAC5 or HDAC9 has been associated with binding and silencing myocyte enhancer factor 2C (MEF2C), leading to a higher susceptibility to cardiac hypertrophy and cardiac failure [89]. Here, HDAC9 is linked to cardiac hypertrophy.